IBL C1Q-CIC CIA TEST— 510(k) K032254

Substantially Equivalent

Ibl GmbH

FDA 510(k) clearance K032254 for IBL C1Q-CIC CIA TEST, Substantially Equivalent on 2003-08-29. Applicant: Ibl GmbH.

Clearance details

Applicant: Ibl GmbH
Product code: Code DAK
Advisory panel: Immunology
Date received: 2003-07-22
Decision date: 2003-08-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: East Stroudsburg, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.